EG17255A - Esters of aryloxypropanolamine derivatives - Google Patents

Esters of aryloxypropanolamine derivatives

Info

Publication number
EG17255A
EG17255A EG670/82A EG67082A EG17255A EG 17255 A EG17255 A EG 17255A EG 670/82 A EG670/82 A EG 670/82A EG 67082 A EG67082 A EG 67082A EG 17255 A EG17255 A EG 17255A
Authority
EG
Egypt
Prior art keywords
esters
aryloxypropanolamine derivatives
aryloxypropanolamine
derivatives
Prior art date
Application number
EG670/82A
Other languages
English (en)
Original Assignee
American Hospital Supply Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Hospital Supply Corp filed Critical American Hospital Supply Corp
Application granted granted Critical
Publication of EG17255A publication Critical patent/EG17255A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/101,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/04Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
    • C07C275/06Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton
    • C07C275/14Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/215Radicals derived from nitrogen analogues of carbonic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/34Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EG670/82A 1981-11-12 1982-11-13 Esters of aryloxypropanolamine derivatives EG17255A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32077281A 1981-11-12 1981-11-12

Publications (1)

Publication Number Publication Date
EG17255A true EG17255A (en) 1990-08-30

Family

ID=23247810

Family Applications (1)

Application Number Title Priority Date Filing Date
EG670/82A EG17255A (en) 1981-11-12 1982-11-13 Esters of aryloxypropanolamine derivatives

Country Status (13)

Country Link
EP (1) EP0093155B1 (fr)
JP (1) JPS58501725A (fr)
AU (1) AU555517B2 (fr)
CA (1) CA1201437A (fr)
DE (1) DE3272925D1 (fr)
EG (1) EG17255A (fr)
ES (2) ES8401012A1 (fr)
GR (1) GR78295B (fr)
IL (1) IL67242A0 (fr)
IT (1) IT1149117B (fr)
NZ (1) NZ202229A (fr)
WO (1) WO1983001772A1 (fr)
ZA (1) ZA827646B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE56108B1 (en) * 1982-07-16 1991-04-24 Carpibem 1-(2-carbalkoxy-4-(thienylcarboxamido)phenoxy)-3-amino 2-propanols,their preparation and applications thereof in therapeutics
US4508725A (en) * 1982-12-22 1985-04-02 American Hospital Supply Corporation Esters of 3-(3-substituted-amino-2-hydroxypropoxy)-4-substituted-1,2,5-thiadiazole derivatives
US5334601A (en) * 1984-03-14 1994-08-02 Bodor Nicholas S Soft β-adrenergic blocking agents
US4829086A (en) * 1984-03-14 1989-05-09 Bodor Nicholas S Soft β-adrenergic blocking agents
US5202347A (en) * 1984-03-14 1993-04-13 Bodor Nicholas S Soft β-adrenergic blocking agents
US5135926A (en) * 1984-03-14 1992-08-04 Bodor Nicholas S Soft β-adrenergic blocking agents
US4593039A (en) * 1984-04-02 1986-06-03 Merck & Co., Inc. 1-aryloxy-3-(substituted aminoalkylamino)-2-propanols
US4605513A (en) * 1984-08-08 1986-08-12 Eli Lilly And Company Process for inhibiting peptide carbamylation
AU2061588A (en) * 1987-09-07 1989-03-09 Imperial Chemical Industries Plc Phenol ester of xamoterol
US5229412A (en) * 1988-03-25 1993-07-20 The Board Of Trustees Of The Leland Stanford Junior University Method for relieving anxiety using 5-hydroxytryptamine-1a-receptor-binding compounds
US4935422A (en) * 1988-12-15 1990-06-19 E. I. Du Pont De Nemours And Company Acyloxypropanolamines
CA2015730C (fr) * 1989-05-12 1997-10-07 Sadahiko Iguchi Esters de l'acide phenylalcanoique

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2132570B1 (fr) * 1971-04-09 1974-08-02 Lipha
US3729477A (en) * 1971-09-09 1973-04-24 Frosst & Co Charles E Certain 4-(3-amino-2-hydroxypropoxy)-1,2,5-thiadiazole-3-carboxamides
US4083992A (en) * 1972-12-15 1978-04-11 Imperial Chemical Industries Limited Alkanolamine derivatives

Also Published As

Publication number Publication date
ZA827646B (en) 1983-08-31
IT1149117B (it) 1986-12-03
ES8500884A1 (es) 1984-11-01
CA1201437A (fr) 1986-03-04
IT8249476A0 (it) 1982-11-12
GR78295B (fr) 1984-09-26
JPS58501725A (ja) 1983-10-13
NZ202229A (en) 1985-11-08
IL67242A0 (en) 1983-03-31
AU555517B2 (en) 1986-09-25
ES517295A0 (es) 1983-12-01
WO1983001772A1 (fr) 1983-05-26
EP0093155A1 (fr) 1983-11-09
EP0093155B1 (fr) 1986-08-27
EP0093155A4 (fr) 1984-04-24
DE3272925D1 (en) 1986-10-02
ES8401012A1 (es) 1983-12-01
ES523878A0 (es) 1984-11-01

Similar Documents

Publication Publication Date Title
AU552609B2 (en) Inner ester derivatives of gangliosides
DE3265843D1 (en) Process for the preparation of carbonate esters
EG17255A (en) Esters of aryloxypropanolamine derivatives
GB8415092D0 (en) Ester derivatives
GB2151629B (en) Apovincaminic acid ester derivatives
JPS57134474A (en) Manufacture of lactone
ZA826927B (en) Preparation of nitrite esters
JPS57192378A (en) Manufacture of furan derivative
JPS57154180A (en) Manufacture of furan derivatives
JPS57212158A (en) Manufacture of s-arylthioglycolic acids
ZA826339B (en) Ester derivatives of n-arylsulfinyl-n-phosphonomethylglycinates
DE3161608D1 (en) Derivatives of phenoxy-phenoxy-carboxylic acids
ZA826338B (en) Ester derivatives of n-arylsufinyl-n-phosphonomethylglycinonitrile
GB2101122B (en) Purification of sucrose esters
ZA827270B (en) Thiosulfenamide derivatives of n-phosphonomethylglycinonitriles
DE3264312D1 (en) Process for the preparation of n-formyl-alpha-amino-acid esters
DE3265855D1 (en) The preparation of derivatives of dichloroacetic acid esters
IL66413A0 (en) Preparation of alpha-hydroxyphophonic acid esters
GB8504116D0 (en) Preparation of acid esters
JPS57134434A (en) Synthesis of 3-keto-cyclopentene-5-oxy derivatives
GB8314001D0 (en) Preparation of alphahaloalkyl esters
EP0158957A3 (en) Allophanic-acid ester derivatives
JPS56115746A (en) Hydroxyaminomethyl derivatives of benzoylldiisubstituteddalphaaphenoxyalkanoyl esters
JPS57169461A (en) Phenoxypyridylmethyl esters
GB2110665B (en) Preparation of aminocyclopentanealkenoic acids